COR Insider Trading

Insider Ownership Percentage: 10.80%
Insider Buying (Last 12 Months): $109,290.00
Insider Selling (Last 12 Months): $1,507,555,785.82

Cencora Insider Trading History Chart

This chart shows the insider buying and selling history at Cencora by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2B$0$2BTotal Insider BuyingTotal Insider Selling

Cencora Share Price & Price History

Current Price: $287.02
Price Change: Price Increase of +2.583 (0.91%)
As of 04/17/2025 04:59 PM ET

This chart shows the closing price history over time for COR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$287.02Closing price on 04/18/25:

SEC Filings (Institutional Ownership Changes) for Cencora (NYSE:COR)

97.52% of Cencora stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at COR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$609Mbought$28MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$10B-$5B$0$5B$10BTotal InflowsTotal Outflows
Cencora logo
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Read More on Cencora

Today's Range

Now: $287.02
Low: $281.65
High: $287.84

50 Day Range

MA: $264.00
Low: $241.37
High: $289.41

52 Week Range

Now: $287.02
Low: $214.77
High: $296.65

Volume

1,617,494 shs

Average Volume

1,509,017 shs

Market Capitalization

$55.66 billion

P/E Ratio

40.83

Dividend Yield

0.79%

Beta

0.55

Who are the company insiders with the largest holdings of Cencora?

Cencora's top insider investors include:
  1. Walgreens Boots Alliance, Inc (Major Shareholder)
  2. Steven H Collis (CEO)
  3. Steven H Collis (Chairman)
  4. Robert P Mauch (CEO)
  5. Gina Clark (EVP)
  6. Robert P Mauch (COO)
  7. Dermot Mark Durcan (Director)
  8. Silvana Battaglia (EVP)
  9. Lazarus Krikorian (CAO)
  10. Elizabeth S Campbell (EVP)
  11. Leslie E Donato (EVP)
Learn More about top insider investors at Cencora.

Who are the major institutional investors of Cencora?

Cencora's top institutional shareholders include:
  1. GAMMA Investing LLC — 0.82%
  2. Rhumbline Advisers — 0.21%
  3. Handelsbanken Fonder AB — 0.16%
  4. Wealth Enhancement Advisory Services LLC — 0.14%
  5. Assenagon Asset Management S.A. — 0.14%
  6. Unigestion Holding SA — 0.08%
Learn More about top institutional investors of Cencora stock.

Which institutional investors are selling Cencora stock?

In the last quarter, COR stock was sold by these institutional investors:
  1. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH
  2. Tobam
  3. Beacon Financial Group
  4. Union Bancaire Privee UBP SA
  5. Wedge Capital Management L L P NC
  6. Fort Washington Investment Advisors Inc. OH
  7. Milestone Asset Management LLC
  8. Avanza Fonder AB
During the previous year, company insiders that have sold Cencora company stock include:
  1. Walgreens Boots Alliance, Inc (Major Shareholder)
  2. Steven H Collis (CEO)
  3. Steven H Collis (Chairman)
  4. Robert P Mauch (CEO)
  5. Gina Clark (EVP)
  6. Robert P Mauch (COO)
  7. Dermot Mark Durcan (Director)
  8. Silvana Battaglia (EVP)
Learn More investors selling Cencora stock.

Which institutional investors are buying Cencora stock?

Within the previous quarter, COR stock was purchased by institutional investors including:
  1. GAMMA Investing LLC
  2. Assenagon Asset Management S.A.
  3. SG Americas Securities LLC
  4. Janney Montgomery Scott LLC
  5. Unigestion Holding SA
  6. American Institute for Advanced Investment Management LLP
  7. Livforsakringsbolaget Skandia Omsesidigt
  8. SOA Wealth Advisors LLC.